Neuromodulation Devices Market to Hit USD 9.34 Billion by 2026; Increasing Patient Population Worldwide to Feed Market Expansion: Fortune Business Insights™

    NEXT STORY
    Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19
    PREV STORY
    Audited Full Year Results for the year ended 31 December 2019
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Advancements in the Treatment of Myelodysplastic Syndromes and RAS-Mutated Lung Cancers to be Presented by Key Opinion Leaders on Thursday, February 7, 2019, in New York City

    Invitation-only breakfast event sponsored by Onconova Therapeutics will also be webcast, beginning at 8:00 ...

    author_avatar
    NASDAQ Market News

    Immune Design to Report Third Quarter 2017 Financial Results & Provide Corporate Update

    SEATTLE and SOUTH SAN FRANCISCO, Calif., Oct. 27, 2017 (GLOBE NEWSWIRE) -- Immune Design ...

    author_avatar
    NASDAQ Market News

    Gritstone Oncology to Webcast Presentations from Two Upcoming Investor Conferences in September

    author_avatar
    NASDAQ Market News